Healthcare IPOs Raise $4.7B as Odyssey Therapeutics and Mobia Debuts Underperform
Healthcare IPOs raised $4.7B as Odyssey Therapeutics and Mobia shares debuted below their offer prices on the first trading day. Despite the sizable proceeds, both stocks slipped after listing, highlighting investor caution toward new clinical-stage healthcare issues.
1. Strong Fundraising but Mixed Results
Healthcare companies generated $4.7 billion in IPO proceeds this week, led by listings from Odyssey Therapeutics and Mobia. The total marks one of the largest capital raises for the sector so far in 2026.
2. Odyssey Therapeutics Debut Underperforms
Odyssey shares opened below their initial offer price and traded lower throughout the session, signaling tempered investor enthusiasm for its late-stage drug pipeline.
3. Mobia Shares Slip on Listing
Mobia’s stock also fell beneath its IPO price on day one, reflecting broader wariness toward early clinical-stage healthcare ventures in a volatile market environment.
4. Implications for Healthcare IPO Pipeline
The combination of strong fundraising and underwhelming share performance suggests greater selectivity among investors, which may increase pressure on pricing for upcoming healthcare listings.